Cisplatin modulates B-cell translocation gene 2 to attenuate cell proliferation of prostate carcinoma cells in both p53-dependent and p53-independent pathways.
Chiang, Kun-Chun
Cisplatin modulates B-cell translocation gene 2 to attenuate cell proliferation of prostate carcinoma cells in both p53-dependent and p53-independent pathways. [electronic resource] - Scientific reports Jul 2014 - 5511 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
2045-2322
10.1038/srep05511 doi
Antineoplastic Agents--administration & dosage
Cell Line, Tumor
Cell Proliferation--drug effects
Cisplatin--administration & dosage
Dose-Response Relationship, Drug
Humans
Immediate-Early Proteins--metabolism
Male
Prostatic Neoplasms--drug therapy
Protein Serine-Threonine Kinases--metabolism
Signal Transduction--drug effects
Treatment Outcome
Tumor Suppressor Protein p53--metabolism
Tumor Suppressor Proteins--metabolism
NF-kappaB-Inducing Kinase
Cisplatin modulates B-cell translocation gene 2 to attenuate cell proliferation of prostate carcinoma cells in both p53-dependent and p53-independent pathways. [electronic resource] - Scientific reports Jul 2014 - 5511 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
2045-2322
10.1038/srep05511 doi
Antineoplastic Agents--administration & dosage
Cell Line, Tumor
Cell Proliferation--drug effects
Cisplatin--administration & dosage
Dose-Response Relationship, Drug
Humans
Immediate-Early Proteins--metabolism
Male
Prostatic Neoplasms--drug therapy
Protein Serine-Threonine Kinases--metabolism
Signal Transduction--drug effects
Treatment Outcome
Tumor Suppressor Protein p53--metabolism
Tumor Suppressor Proteins--metabolism
NF-kappaB-Inducing Kinase